- Home
- CRNX vs INSP Comparison
CRNX vs INSP Comparison
Compare CRNX & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | INSP |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.8B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CRNX | INSP |
|---|---|---|
| Price | $45.24 | $124.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $71.00 | ★ $130.79 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | N/A | ★ 1.48 |
| Revenue | $1,535,000.00 | ★ $882,622,000.00 |
| Revenue This Year | $405.68 | $14.83 |
| Revenue Next Year | $1,034.87 | $14.44 |
| P/E Ratio | ★ N/A | $84.36 |
| Revenue Growth | ★ 47.74 | 16.81 |
| 52 Week Low | $24.10 | $70.77 |
| 52 Week High | $60.34 | $216.01 |
Technical Indicators
Market Signals| Indicator | CRNX | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 77.56 |
| Support Level | $43.07 | $81.79 |
| Resistance Level | $45.16 | $138.80 |
| Average True Range (ATR) | 2.04 | 5.73 |
| MACD | 0.24 | 4.90 |
| Stochastic Oscillator | 79.37 | 76.57 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.